SENORES PHARMACEUTICALS L (SENORES.NS)
- Previous Close
525.75 - Open
528.20 - Bid --
- Ask --
- Day's Range
521.30 - 541.95 - 52 Week Range
435.25 - 665.00 - Volume
385,413 - Avg. Volume
492,524 - Market Cap (intraday)
24.542B - Beta (5Y Monthly) --
- PE Ratio (TTM)
33.12 - EPS (TTM)
16.09 - Earnings Date May 15, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
880.00
Senores Pharmaceuticals Limited develops, manufactures, and sells, pharmaceutical products in India, the United States, Canada, and internationally. The company offers tablets, capsules, liquids, dry syrups, oral rehydration solutions, active pharmaceutical ingredients, and critical care injectables, including antibiotics, anti-bacterial, anti-fungal, and blood line. It also exports its products. The company provides consulting and licensing services. Senores Pharmaceuticals Limited was incorporated in 2017 and is based in Ahmedabad, India.
senorespharma.com--
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: SENORES.NS
View MorePerformance Overview: SENORES.NS
Trailing total returns as of 6/6/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SENORES.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SENORES.NS
View MoreValuation Measures
Market Cap
24.21B
Enterprise Value
22.34B
Trailing P/E
32.61
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.80
Price/Book (mrq)
3.08
Enterprise Value/Revenue
5.61
Enterprise Value/EBITDA
20.50
Financial Highlights
Profitability and Income Statement
Profit Margin
14.70%
Return on Assets (ttm)
4.93%
Return on Equity (ttm)
11.18%
Revenue (ttm)
3.98B
Net Income Avi to Common (ttm)
585.6M
Diluted EPS (ttm)
16.09
Balance Sheet and Cash Flow
Total Cash (mrq)
3.86B
Total Debt/Equity (mrq)
38.75%
Levered Free Cash Flow (ttm)
-2.42B